Deterioro neuropsicológico en sujetos con trastorno bipolar en fase de eutimia

  1. Jessica Brea Pereiro 1
  2. Rosa Jurado Barba 1
  3. M. José Álvarez Alonso
  4. Gabriel Rubio Valladolid
  5. Isabel Martínez Gras
  1. 1 Universidad Camilo José Cela. Departamento de Psicología
Revista:
EduPsykhé: Revista de psicología y educación

ISSN: 1579-0207

Ano de publicación: 2014

Volume: 13

Número: 2

Páxinas: 147-160

Tipo: Artigo

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Outras publicacións en: EduPsykhé: Revista de psicología y educación

Resumo

Recovery bipolar disorder in euthymic phase is characteristic for its definition, but it is known that the neuropsychological deterioration persists during the residual phase. Diverse studies suggest the maintenance of cognitive deficiencies in asymptomatic patients. The objective of this study is to evaluate the possible cognitive dysfunction of bipolar patients in the state of euthymia through a battery of tests that examines capacities such as memory and inhibitory functions, comparing the scores of eleven bipolar disorder patients to those of fourteen healthy subjects through a set of neuropsychological tests. In general, the bipolar patients obtained worse scores concerning the control group; so it is important to point out the evidence of stable and durable cognitive deterioration in all of the phases of bipolar disorder, including the remission phase (euthymia), in particular, in the next fields: verbal learning, memory and executive functions.

Referencias bibliográficas

  • Alonso, J., Prieto, L., Antó, J.M. (1995). La versión española del SF -36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Medicina Clínica ,104(20), 771-776.
  • Austin, M. P., Ross, M., Murray, C., O’Carroll, R.E., Ebmeier, K.P. y Goodwin, G.M. (1992). Cognitive function in major depression. Journal of Affective Disorders, 25(1), 21-30.
  • Belloch, A., Sandín, B. y Ramos, F. (2008). Manual de Psicopatología. Volumen I. Madrid: McGraw-Hill.
  • Bender, S., Dittmann-Balcar A., Schall, U. (2006). Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine. Int J Neuropsychopharmaco, 9, 135-145.
  • Benedet, M.J. y Alejandre, M.A. (1988). Test de aprendizaje verbal España-Complutense (TAVEC). TEA ediciones.
  • Bora, E., Yucel, M., Pantelis, C. (2009). Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. Journal of Affective Disorders, 113(1-2), 1- 20.
  • Buchanan, R.W., Holstein, C., Breier, A. (1994). The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry, 36, 717-725.
  • Burt, D.B., Zembar, M.J. y Niederehe, G. (1995). Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychological Bulletin, 117, 285-305.
  • Castanho de Almeida Rocca, C., Van den Heuvel, E., Caetano, C.S., y Lafer, B. (2009). Facial emotion recognition in bipolar disorder: a criticalreview. Revista Brasileira de Psiquiatria, 31(2), 171-180.
  • Cavanagh, J.T.O., van Beck, M., Muir, W., y Blackwood, D. (2002). Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. The British Journal of Psychiatry, 180, 320-326.
  • Clark, L., Iversen, S.D.y Goodwin M. (2002). Sustained attention deficit in bipolar disorder. The British Journal of Psychiatry, 180, 313-319.
  • Doyle, A.,Wilens, T., Kwon, A., Seidman, L.J., Faraone , S.V., Fried, R., Swezey, A., Snyder, L y Biederman, J. (2005). Neuropsychological functioning in youth with bipolar disorder. Biological Psychiatry, 58 (7), 540-548.
  • Ferrier, I.N. y Thompson, M.J. (2002). Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. The British Journal of Psychiatry, 180, 293-295.
  • Galletly, C.A., Clark, C.R., McFarlane, A.C. (2000). The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Neuropsychopharmacol Biol Psychiatry, 24, 1.329-1.338.
  • Golden, C. 1994, Stroop Test de Colores y de Palabras, Madrid. TEA Ediciones.
  • Grant, D.A., y Berg, E.A. (1948). A behavioural analysis of degree of reinforcement and ease of shifting to new responses in a weigl-type card sorting problem. Journal of Experimental Psychology, 38, 404-411.
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry (23), 56-62.
  • Kurtz , M.M., y Gerraty, R.T. (2009). A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology, 23(5), 551-562.
  • Latalova, K., Prasko, J., Diveky, T., y Velartova, H. (2011). Cognitive impairment in bipolar disorder. Biomedical Papers, 155(1), 19-26.
  • Purdon, S.E., Jones, B.D., Stip, E, (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry, 57, 249-58.
  • MacQueen, G.M., Young, L.T., Robb, J.C., Marriott, M., Cooke, R.G., y Joffe R.T. (2000) Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psych Scand, 101(5), 374-381.
  • Martino, J.D., Strejilevich, S.A., Marengo, E., Igoa, A., Fassi, G., Teitelbaum, J. y Caravotta, P. (2012). Relationship between neurocognitive functioning and episode recurrences in bipolar disorder. Journal of Affective Disorders, 147, (1-3), 345-351.
  • Mur, M., Portella, M.J., Martinez-Aran, A., Pifarre, J., yVieta, E. (2009). Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology, 42(3), 148-156.
  • Murphy, F.C., Rubinsztein, J.S., y Michael, A. (2001). Decision-making cognition in mania and depression. Psychological Medicine, 31, 679-694.
  • Murphy, F. C., Sahakian, B. J., Rubinsztein, J. S., Michael, A., Rogers, R.D., Robbins, T.W., y Paykel, E.S. (1999). Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine, 29 (6), 1.307-1.321.
  • Murphy, F.C., y Sahakian, B.J. (2001). Neuropsychology of bipolar disorder. The British Journal of Psychiatry, 178, 120-127.
  • Redondo, J., Fraga, I., Comesaña, M., y Perea, M. (2005). Estudio normativo del valor afectivo de 478 palabras españolas. Psicológica, 26, 317-326.
  • Reitan, R.M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271-27.
  • Riedel, M., Muller, N., Spellmann, I. (2007). Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Psychiatry Clinic Neuroscience, 257, 402-412.
  • Rubinsztein, J.S., Michael, A., Paykel, E.S., y Sahakian, B.J. (2000). Cognitive impairment in remission in bipolar affective disorder. Psychological Medicine, 30 (5), 1.025-1.036.
  • Sánchez-Moreno, J., Martínez-Aran, A., Tabares-Seisdedos, R., Torrent, C., Vieta, E., Ayuso-Mateos, J.L. (2009). Functioning and disability in bipolar disorder: An extensive review. Psychother Psychosom, 78, 285-97.
  • Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society of London , 298, 199-209.
  • Taylor, M.A., y Abrams, R. (1986). Cognitive dysfunction in mania. Comprehensive Psychiatry, 27, 186-191.
  • Thompson, J.M., Gray, J.M., Crawford, J.R., Hughes, J.H,. Young, A.H., y Ferrier, I.N. (2009). Differential deficit in executive control in euthymic bipolar disorder. Journal of Abnormal Psychology, 118(1), 146-160.
  • Thornton, A.E., Van Snellenberg, J.X., Sepehry, A.A., Honer, W. (2006). The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review. J Psychopharmacol, 20, 335-346.
  • Van der werf-eldering, M.J., Schouws, S., Arts., B., y Jabben, N. (2012). Cognitievestoornissenbijpatiënten met eenbipolairestoornis: determinanten en consequenties. Tijdschrift Voor Psychiatrie, 54(2012)8, 709-718.
  • Velligan, D.I., Newcomer, J., Pultz, J., Csernansky, J., Hoff, A.L., Mahurin, R., Miller, A.L. (2002). Does cognitive function improve with quetiapine in comparison to haloperidol?
Fonte de datos: Dialnet